At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- HF-guided VA (other), Standard-of-care (other)
- How long the study runs
- Study runs about 40 months (dates as stated)
- About the drug or intervention
- HF-guided VA — other: VA guided recommendation · Standard-of-care — other: Standard-of-care
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 60
- Started
- 2024-05-07
- Last checked
- 2024-07
Plain English Summary
What is this study?
- • Testing a new treatment for heart failure
- • NA - 60 participants
- • The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with heart failure
Where?
- • Stevenage - East and North Hertfordshire NHS Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Age ≥ 18 years
- ✓Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge
- ✓Exclusion Criteria
- ✓Known prior history of HF
- ✓Severe other health conditions that could affect protocol adherence, in the opinion of the investigator
See the full criteria
Where Is This Study? (1 UK site)
East and North Hertfordshire NHS Trust
Stevenage SG1 4AB, United Kingdom
How to Get in Touch
Joshua H Leader, MBChB, BSc
Sponsor contactCONTACT
Diana A Gorog, MD, PhD
Sponsor contactCONTACT